Hillestad Pharmaceuticals USA, Inc.
FDA-inspected organization
Hillestad Pharmaceuticals USA, Inc. has been audited by the FDA 20 times between 2000 and 2024 across all 1 sites.
Documents
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2023
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2019
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2018
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2016
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2014
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2013
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2012
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2011
Out of stock
FDA 483 Hillestad Pharmaceuticals USA, Inc., Woodruff | 2003
Out of stock
FDA Investigators (15)
- Sarah A. Palmer, FDA Investigator
- Douglas J. Snyder, FDA Investigator
- Patrick J. Campbell, FDA Investigator
- Jesse P. Romenesko, FDA Investigator
- Jennifer Guttuso, FDA Investigator
- Courtney R. Ingalsbe, FDA Investigator
- James K. Ireland, FDA Investigator
- Courtney R. Tiegs, FDA Investigator
- Katherine A. Clarke Girolamo, FDA Investigator
- Clarke Girolamo, Katherine A, FDA Investigator
- Ivan E. Reyes, FDA Investigator
- April L. Young, FDA Investigator
- Justin A. Boyd, FDA Investigator
- Kenneth A. Libertoski, FDA Investigator
- John P. Hermann, FDA Investigator